These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification. Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P. Cancer; 2002 Feb 01; 94(3):854-61. PubMed ID: 11857322 [Abstract] [Full Text] [Related]
6. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications. Popov Z, Gil-Diez-De-Medina S, Ravery V, Hoznek A, Bastuji-Garin S, Lefrere-Belda MA, Abbou CC, Chopin DK. Urol Oncol; 2004 Feb 01; 22(2):93-101. PubMed ID: 15082004 [Abstract] [Full Text] [Related]
7. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas. Voss SM, Riley MP, Lokhandwala PM, Wang M, Yang Z. Am J Surg Pathol; 2015 Jan 01; 39(1):13-24. PubMed ID: 25353284 [Abstract] [Full Text] [Related]
11. Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma. Giannopoulos G, Kavantzas N, Parasi A, Tiniakos D, Peros G, Tzanakis N, Patsouris E, Pavlakis K. Pancreas; 2007 Jul 25; 35(1):47-52. PubMed ID: 17575545 [Abstract] [Full Text] [Related]
13. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome. Tsamandas AC, Kardamakis D, Tsiamalos P, Liava A, Tzelepi V, Vassiliou V, Petsas T, Vagenas K, Zolota V, Scopa CD. Anticancer Res; 2009 Feb 25; 29(2):703-9. PubMed ID: 19331225 [Abstract] [Full Text] [Related]
14. Variant of intraductal carcinoma (with scant mucin production) is of main pancreatic duct origin: a clinicopathological study of four patients. Suda K, Hirai S, Matsumoto Y, Mogaki M, Oyama T, Mitsui T, Fujibayashi M, Kumazawa K, Kajiwara T. Am J Gastroenterol; 1996 Apr 25; 91(4):798-800. PubMed ID: 8677955 [Abstract] [Full Text] [Related]
15. Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Uehara H, Miyamoto M, Kato K, Ebihara Y, Kaneko H, Hashimoto H, Murakami Y, Hase R, Takahashi R, Mega S, Shichinohe T, Kawarada Y, Itoh T, Okushiba S, Kondo S, Katoh H. Cancer Res; 2004 May 15; 64(10):3533-7. PubMed ID: 15150108 [Abstract] [Full Text] [Related]
16. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A. BMC Cancer; 2007 Aug 10; 7():156. PubMed ID: 17692120 [Abstract] [Full Text] [Related]
17. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Gilks CB, Ionescu DN, Kalloger SE, Köbel M, Irving J, Clarke B, Santos J, Le N, Moravan V, Swenerton K, Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency. Hum Pathol; 2008 Aug 10; 39(8):1239-51. PubMed ID: 18602670 [Abstract] [Full Text] [Related]
18. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. Chhieng DC, Benson E, Eltoum I, Eloubeidi MA, Jhala N, Jhala D, Siegal GP, Grizzle WE, Manne U. Cancer; 2003 Dec 25; 99(6):365-71. PubMed ID: 14681945 [Abstract] [Full Text] [Related]
19. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type. Stefansson IM, Salvesen HB, Immervoll H, Akslen LA. Histopathology; 2004 May 25; 44(5):472-9. PubMed ID: 15139995 [Abstract] [Full Text] [Related]
20. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer. Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ. Anticancer Res; 2002 May 25; 22(6B):3759-64. PubMed ID: 12552989 [Abstract] [Full Text] [Related] Page: [Next] [New Search]